atpE Family assigned · medium auto-curated

H37Rv Rv1305 · MTBC0 mtbc0_001397 · 81 aa · 1470084–1470329 MTBC0 (+) · RefSeq NP_215821.1

Genomic neighbourhood (genome browser)

Open in full genome browser →
+ strand − strand lysA (Rv1293) — requalified: diaminopimelate decarboxylase thrA (Rv1294) — requalified: homoserine dehydrogenase thrA thrC (Rv1295) — requalified: threonine synthase thrC thrB (Rv1296) — requalified: homoserine kinase thrB rho (Rv1297) — requalified: transcription termination factor Rho rho rpmE (Rv1298) — requalified: 50S ribosomal protein L31 prfA (Rv1299) — requalified: peptide chain release factor 1 prfA hemK (Rv1300) — requalified: peptide chain release factor N(5)-glutamine methyltransferas hemK Rv1301 (Rv1301) — requalified: L-threonylcarbamoyladenylate synthase rfe (Rv1302) — requalified: UDP-N-acetylglucosamine--decaprenyl-phosphate N-acetylglucos rfe Rv1303 (Rv1303) — family_assigned: ATP synthase subunit I atpB (Rv1304) — family_assigned: F0F1 ATP synthase subunit A atpE (Rv1305) — family_assigned: F0F1 ATP synthase subunit C atpF (Rv1306) — family_assigned: F0F1 ATP synthase subunit B atpH (Rv1307) — family_assigned: F0F1 ATP synthase subunit B/delta atpH atpA (Rv1308) — family_assigned: F0F1 ATP synthase subunit alpha atpA atpG (Rv1309) — family_assigned: F0F1 ATP synthase subunit gamma atpG atpD (Rv1310) — family_assigned: F0F1 ATP synthase subunit beta atpD atpC (Rv1311) — family_assigned: F0F1 ATP synthase subunit epsilon Rv1312 (Rv1312) — family_assigned: DUF2550 domain-containing protein Rv1314c (Rv1314c) — requalified: cob(I)yrinic acid a%2Cc-diamide adenosyltransferase murA (Rv1315) — requalified: UDP-N-acetylglucosamine 1-carboxyvinyltransferase murA 1 460 kb 1 464 kb 1 468 kb 1 472 kb 1 476 kb 1 480 kb

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)ATP synthase subunit C
MTBC0 PGAP re-annotationF0F1 ATP synthase subunit C
Revised (this work)F0F1 ATP synthase subunit C. Pfam: ATP-synt_C (PF00137.27).
Functional category (TubercuList)intermediary metabolism and respiration

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 96 publications

96 TB publications mention this gene. 96 publications discuss this gene. Queried separately, 87 records carry a M. tuberculosis context and 9 a non-TB mycobacterial context (species named in the 9-record verified sample: M. abscessus (7), M. smegmatis (2)). The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 96: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Phenotypic drug susceptibility testing and genotypic characterization of Bedaquiline resistance in drug resistant Mycobacteriumtuberculosis. doi:10.1016/j.ijmmb.2026.101163 2026
Bedaquiline resistance-associated genetic mutations and minimum inhibitory concentrations in drug-resistant tuberculosis clinical isolates from Limpopo province, South Africa. doi:10.3389/fmicb.2026.1803115 2026
Global mapping of bedaquiline-resistant Mycobacterium tuberculosis: a systematic review. doi:10.1186/s12879-026-13171-3 2026
Bedaquiline Resistance in Drug-Resistant Tuberculosis in South Africa: A Systematic Review and Meta-Analysis of Emerging Trends. doi:10.3390/antibiotics15040385 2026
Comparative transcriptomic profiling of pyrazinamide resistance in Mycobacterium tuberculosis. doi:10.1093/jambio/lxag064 2026
100 records returned by the alias sweep (a separate sweep from the 96 above; both are shown, neither is exhaustive)

Searched as: Rv1305, atpE, Mb1337, ML1140, MMAR_4092, MSMEG_4941, MAB_1448 — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
Genomic and structural insights into the atpB L173I substitution: modulation of the F₀ rotor architecture in Mycobacterium tuberculosis ATP synthase and altered Bedaquiline binding dynamics. doi:10.1007/s11274-026-05173-9 World J Microbiol Biotechnol 2026
No phenotypic resistance observed for most group-3 and -4 variants in Mycobacterium tuberculosis genes related to bedaquiline, clofazimine, delamanid, and pretomanid in a Central and West African context. doi:10.1128/spectrum.02005-26 Microbiol Spectr 2026
In vitro pharmacokinetics and pharmacodynamics of the diarylquinoline TBAJ-587 and its metabolites against Mycobacterium tuberculosis. doi:10.3389/fmicb.2026.1828998 Front Microbiol 2026
Phenotypic drug susceptibility testing and genotypic characterization of Bedaquiline resistance in drug resistant Mycobacteriumtuberculosis. doi:10.1016/j.ijmmb.2026.101163 Indian J Med Microbiol 2026
Bedaquiline resistance-associated genetic mutations and minimum inhibitory concentrations in drug-resistant tuberculosis clinical isolates from Limpopo province, South Africa. doi:10.3389/fmicb.2026.1803115 Front Microbiol 2026
Global mapping of bedaquiline-resistant Mycobacterium tuberculosis: a systematic review. doi:10.1186/s12879-026-13171-3 BMC Infect Dis 2026
Bedaquiline Resistance in Drug-Resistant Tuberculosis in South Africa: A Systematic Review and Meta-Analysis of Emerging Trends. doi:10.3390/antibiotics15040385 Antibiotics (Basel) 2026
Comparative transcriptomic profiling of pyrazinamide resistance in Mycobacterium tuberculosis. doi:10.1093/jambio/lxag064 J Appl Microbiol 2026
Integrating structure-guided and fragment-based inhibitor design to combat bedaquiline resistant Mycobacterium tuberculosis: a molecular dynamics study. doi:10.1080/07391102.2024.2441426 J Biomol Struct Dyn 2026
A novel one-tube nested fluorescence melting curve analysis for rapid detection of drug-resistant Mycobacterium tuberculosis. doi:10.1186/s12866-025-04601-4 BMC Microbiol 2025
Bedaquiline Resistance: A Looming Global Threat in Tuberculosis Management. doi:10.1007/s00284-025-04655-7 Curr Microbiol 2025
Whole genome sequencing-based detection of extensively drug-resistant tuberculosis from Ethiopia. doi:10.1038/s43856-025-01271-1 Commun Med (Lond) 2025
Mutations in the atpE gene and bedaquiline resistance in Mycobacterium avium. doi:10.1016/j.jgar.2025.10.004 names it J Glob Antimicrob Resist 2025
Effect of Bdq-Containing Regimen and Molecular Detection of Bdq Resistance among Pre-XDR-TB Patients with Unfavorable Outcomes. doi:10.2147/IJGM.S538660 Int J Gen Med 2025
Investigation of delamanid, bedaquiline, and linezolid resistance rates and related gene mutations in multidrug-resistant Mycobacterium tuberculosis in regional tuberculosis reference laboratories of Iran. doi:10.1186/s12866-025-04213-y BMC Microbiol 2025
Dinucleotide codon substitutions as a signature of diversifying selection in Mycobacterium tuberculosis. doi:10.3389/fmolb.2025.1511372 Front Mol Biosci 2025
Linking genetic and phenotypic bedaquiline resistance in Mycobacterium tuberculosis strains from Georgia. doi:10.1371/journal.pone.0326794 PLoS One 2025
An improved catalogue for whole-genome sequencing prediction of bedaquiline resistance in Mycobacterium tuberculosis using a reproducible algorithmic approach. doi:10.1099/mgen.0.001429 Microb Genom 2025
[Bedaquiline susceptibility and molecular mutation characteristics of Mycobacterium tuberculosis in Guizhou Province]. doi:10.3760/cma.j.cn112147-20250123-00050 Zhonghua Jie He He Hu Xi Za Zhi 2025
Sudapyridine (WX-081) inhibits Mycobacterium tuberculosis by targeting ATP synthase and upregulating host innate immunity. doi:10.1128/msphere.00149-25 mSphere 2025
High Prevalence of atpE Mutations in Bedaquiline-Resistant Mycobacterium tuberculosis Isolates, Russia. doi:10.3201/eid3103.241488 names it Emerg Infect Dis 2025
In vitro monitoring of drug resistance emergence during stepwise induction of bedaquiline and clofazimine, alone and in combination: a phenotypic and genotypic analysis. doi:10.1093/jac/dkae405 J Antimicrob Chemother 2025
A Narrative Review of Bedaquiline and Delamanid: New Arsenals Against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis. doi:10.1002/jcla.25091 J Clin Lab Anal 2024
Phenotypic and genotypic analysis of drug resistance in M. tuberculosis isolates in Gansu, China. doi:10.1371/journal.pone.0311042 PLoS One 2024
Cartridge-based sequencing for bedaquiline resistance detection from sputum. doi:10.5588/ijtldopen.24.0124 IJTLD Open 2024
Delamanid and bedaquiline resistance patterns in Mycobacterium tuberculosis in Iran: A cross-sectional analysis. doi:10.1016/j.nmni.2024.101437 New Microbes New Infect 2024
Application of a new designed high resolution melting analysis for mycobacterial species identification. doi:10.1186/s12866-024-03361-x BMC Microbiol 2024
The importance of heteroresistance and efflux pumps in bedaquiline-resistant Mycobacterium tuberculosis isolates from Iran. doi:10.1186/s12941-024-00694-3 Ann Clin Microbiol Antimicrob 2024
Identification of genetic determinants of bedaquiline resistance in Mycobacterium tuberculosis in Ural region, Russia. doi:10.1128/spectrum.03749-23 Microbiol Spectr 2024
Opportunities and limitations of genomics for diagnosing bedaquiline-resistant tuberculosis: a systematic review and individual isolate meta-analysis. doi:10.1016/S2666-5247(23)00317-8 Lancet Microbe 2024
Bioactives from medicinal herb against bedaquiline resistant tuberculosis: removing the dark clouds from the horizon. doi:10.1016/j.micinf.2023.105279 Microbes Infect 2024
Genotype-Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis. doi:10.1093/cid/ciad596 Clin Infect Dis 2024
In silico structural and mechanical insights into bedaquiline resistance associated with high-grade non-synonymous mutations in atpE, mmpR5, and pepQ. doi:10.1080/07391102.2023.2259486 names it J Biomol Struct Dyn 2024
Molecular mechanisms of resistance and treatment efficacy of clofazimine and bedaquiline against Mycobacterium tuberculosis. doi:10.3389/fmed.2023.1304857 Front Med (Lausanne) 2023
Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study. doi:10.1016/S2666-5247(23)00172-6 Lancet Microbe 2023
Bedaquiline Resistance and Molecular Characterization of Rifampicin-Resistant Mycobacterium Tuberculosis Isolates in Zhejiang, China. doi:10.2147/IDR.S429003 Infect Drug Resist 2023
Surveillance of multidrug-resistant tuberculosis in sub-Saharan Africa through wastewater-based epidemiology. doi:10.1016/j.heliyon.2023.e18302 Heliyon 2023
Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678. doi:10.1038/s41598-023-36955-y Sci Rep 2023
Mycobacterium tuberculosis - atpE gene profile of bedaquiline-treated pulmonary tuberculosis patients at the referral hospital Dr. Soetomo, Indonesia. doi:10.4103/ijmy.ijmy_40_23 names it Int J Mycobacteriol 2023
A Bayesian approach to estimate the probability of resistance to bedaquiline in the presence of a genomic variant. doi:10.1371/journal.pone.0287019 PLoS One 2023
Site-directed mutagenesis of Mycobacterium tuberculosis and functional validation to investigate potential bedaquiline resistance-causing mutations. doi:10.1038/s41598-023-35563-0 Sci Rep 2023
Bedquiline Resistance Mutations: Correlations with Drug Exposures and Impact on the Proteome in M. tuberculosis. doi:10.1128/aac.01532-22 Antimicrob Agents Chemother 2023
Opportunities and limitations of genomics for diagnosing bedaquiline-resistant tuberculosis: an individual isolate metaanalysis. doi:10.1101/2023.05.04.23289023 medRxiv 2023
Evaluation of genetic mutations associated with phenotypic resistance to fluoroquinolones, bedaquiline, and linezolid in clinical Mycobacterium tuberculosis: A systematic review and meta-analysis. doi:10.1016/j.jgar.2023.05.001 J Glob Antimicrob Resist 2023
Bedaquiline resistance pattern in clofazimine-resistant clinical isolates of tuberculosis patients. doi:10.1016/j.jgar.2023.04.003 J Glob Antimicrob Resist 2023
Targeted Chromosomal Barcoding Establishes Direct Genotype-Phenotype Associations for Antibiotic Resistance in Mycobacterium abscessus. doi:10.1128/spectrum.05344-22 Microbiol Spectr 2023
Emergence of Canonical and Noncanonical Genomic Variants following In Vitro Exposure of Clinical Mycobacterium tuberculosis Strains to Bedaquiline or Clofazimine. doi:10.1128/aac.01368-22 Antimicrob Agents Chemother 2023
New design of multilocus sequence analysis of rpoB, ssrA, tuf, atpE, ku, and dnaK for identification of Mycobacterium species. doi:10.1007/s11033-022-07638-0 names it Mol Biol Rep 2022
Whole Genome Sequencing Identifies Novel Mutations Associated With Bedaquiline Resistance in Mycobacterium tuberculosis. doi:10.3389/fcimb.2022.807095 Front Cell Infect Microbiol 2022
Real-time PCR using atpE, conventional PCR targeting different regions of difference, and flow cytometry for confirmation of Mycobacterium bovis in buffaloes and cattle from the Delta area of Egypt. doi:10.1186/s12866-022-02568-0 names it BMC Microbiol 2022
atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment Failure. doi:10.3201/eid2805.212517 names it Emerg Infect Dis 2022
Variants associated with Bedaquiline (BDQ) resistance identified in Rv0678 and efflux pump genes in Mycobacterium tuberculosis isolates from BDQ naïve TB patients in Pakistan. doi:10.1186/s12866-022-02475-4 BMC Microbiol 2022
In vivo microevolution of Mycobacterium tuberculosis and transient emergence of atpE_Ala63Pro mutation during treatment in a pre-XDR TB patient. doi:10.1183/13993003.02102-2021 names it Eur Respir J 2022
Identification of potent inhibitors of ATP synthase subunit c (AtpE) from Mycobacterium tuberculosis using in silico approach. doi:10.1016/j.heliyon.2021.e08482 names it Heliyon 2021
Genetic variants and their association with phenotypic resistance to bedaquiline in Mycobacterium tuberculosis: a systematic review and individual isolate data analysis. doi:10.1016/s2666-5247(21)00175-0 Lancet Microbe 2021
Primary Bedaquiline Resistance Among Cases of Drug-Resistant Tuberculosis in Taiwan. doi:10.3389/fmicb.2021.754249 Front Microbiol 2021
Genetic diversity of candidate loci linked to Mycobacterium tuberculosis resistance to bedaquiline, delamanid and pretomanid. doi:10.1038/s41598-021-98862-4 Sci Rep 2021
In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates. doi:10.3389/fmicb.2020.559469 Front Microbiol 2020
Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis. doi:10.1016/S2666-5247(20)30031-8 Lancet Microbe 2020
Molecular characteristics and in vitro susceptibility to bedaquiline of Mycobacterium tuberculosis isolates circulating in Shaanxi, China. doi:10.1016/j.ijid.2020.07.044 Int J Infect Dis 2020
A Multimethod, Multicountry Evaluation of Breakpoints for Bedaquiline Resistance Determination. doi:10.1128/AAC.00479-20 Antimicrob Agents Chemother 2020
Mutation in atpE and Rv0678 genes associated with bedaquline resistance among drug-resistant tuberculosis patients: A pilot study from a high-burden setting in Northern India. doi:10.4103/ijmy.ijmy_30_20 names it Int J Mycobacteriol 2020
Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid. doi:10.1093/jac/dkaa136 J Antimicrob Chemother 2020
Whole Genome Sequencing for the Analysis of Drug Resistant Strains of Mycobacterium tuberculosis: A Systematic Review for Bedaquiline and Delamanid. doi:10.3390/antibiotics9030133 Antibiotics (Basel) 2020
Reduced susceptibility and resistance to bedaquiline in clinical M. tuberculosis isolates. doi:10.1016/j.jinf.2020.01.007 J Infect 2020
Nontuberculous Mycobacteria in Two Drinking Water Distribution Systems and the Role of Residual Disinfection. doi:10.1021/acs.est.9b01945 Environ Sci Technol 2019
Empirical ways to identify novel Bedaquiline resistance mutations in AtpE. doi:10.1371/journal.pone.0217169 names it PLoS One 2019
In Vitro Study of Stepwise Acquisition of rv0678 and atpE Mutations Conferring Bedaquiline Resistance. doi:10.1128/AAC.00292-19 names it Antimicrob Agents Chemother 2019
The rapid detection and differentiation of Mycobacterium tuberculosis complex members from cattle and water buffaloes in the delta area of Egypt, using a combination of real-time and conventional PCR. doi:10.1007/s11033-019-04834-3 Mol Biol Rep 2019
Clofazimine Exposure In Vitro Selects Efflux Pump Mutants and Bedaquiline Resistance. doi:10.1128/AAC.02141-18 Antimicrob Agents Chemother 2019
Collated data of mutation frequencies and associated genetic variants of bedaquiline, clofazimine and linezolid resistance in Mycobacterium tuberculosis. doi:10.1016/j.dib.2018.09.057 Data Brief 2018
In vitro approaches for generation of Mycobacterium tuberculosis mutants resistant to bedaquiline, clofazimine or linezolid and identification of associated genetic variants. doi:10.1016/j.mimet.2018.08.011 J Microbiol Methods 2018
Mutations associated with in vitro resistance to bedaquiline in Mycobacterium tuberculosis isolates in Australia. doi:10.1016/j.tube.2018.04.007 Tuberculosis (Edinb) 2018
Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus. doi:10.1128/AAC.00175-18 Antimicrob Agents Chemother 2018
Bedaquiline Resistance: Its Emergence, Mechanism, and Prevention. doi:10.1093/cid/cix992 Clin Infect Dis 2018
Mycobacterial Membrane Proteins QcrB and AtpE: Roles in Energetics, Antibiotic Targets, and Associated Mechanisms of Resistance. doi:10.1007/s00232-017-9997-3 names it J Membr Biol 2018
Importance of Local and Regional Scales in Shaping Mycobacterial Abundance in Freshwater Lakes. doi:10.1007/s00248-017-1088-6 Microb Ecol 2018
Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish. doi:10.1128/AAC.01225-17 Antimicrob Agents Chemother 2017
In vitro activity of bedaquiline against rapidly growing nontuberculous mycobacteria. doi:10.1099/jmm.0.000537 J Med Microbiol 2017
Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region. doi:10.1093/jac/dkx094 J Antimicrob Chemother 2017
In Vitro Activity of Bedaquiline against Nontuberculous Mycobacteria in China. doi:10.1128/AAC.02627-16 Antimicrob Agents Chemother 2017
Emergence of mmpT5 Variants during Bedaquiline Treatment of Mycobacterium intracellulare Lung Disease. doi:10.1128/JCM.02087-16 J Clin Microbiol 2017
Culture-Independent Identification of Nontuberculous Mycobacteria in Cystic Fibrosis Respiratory Samples. doi:10.1371/journal.pone.0153876 PLoS One 2016
Resistance related metabolic pathways for drug target identification in Mycobacterium tuberculosis. doi:10.1186/s12859-016-0898-8 BMC Bioinformatics 2016
atpE gene as a new useful specific molecular target to quantify Mycobacterium in environmental samples. doi:10.1186/1471-2180-13-277 names it BMC Microbiol 2013
Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis? doi:10.1016/j.tube.2013.09.003 Tuberculosis (Edinb) 2013
Insights into the distribution and functions of the eukaryotic GPI-like anchored genes among Mycobacterium from a comparative genomic perspective. doi:10.1615/critreveukargeneexpr.v22.i4.40 Crit Rev Eukaryot Gene Expr 2012
Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor. doi:10.1128/AAC.01611-09 Antimicrob Agents Chemother 2010
Modulation of P2X(7) purinergic receptor in macrophages by Leishmania amazonensis and its role in parasite elimination. doi:10.1016/j.micinf.2009.05.001 Microbes Infect 2009
In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor. doi:10.1128/AAC.00181-07 Antimicrob Agents Chemother 2007
Diarylquinolines target subunit c of mycobacterial ATP synthase. doi:10.1038/nchembio884 Nat Chem Biol 2007
A computational model of the inhibition of Mycobacterium tuberculosis ATPase by a new drug candidate R207910. doi:10.1002/prot.21376 Proteins 2007
Genetic basis for natural and acquired resistance to the diarylquinoline R207910 in mycobacteria. doi:10.1128/AAC.00244-06 Antimicrob Agents Chemother 2006
ATP stimulates human macrophages to kill intracellular virulent Mycobacterium tuberculosis via calcium-dependent phagosome-lysosome fusion. doi:10.4049/jimmunol.167.6.3308 J Immunol 2001
ATP-induced killing of virulent Mycobacterium tuberculosis within human macrophages requires phospholipase D. doi:10.4049/jimmunol.164.1.379 J Immunol 2000
Small genes/gene-products in Escherichia coli K-12. doi:10.1111/j.1574-6968.1998.tb13343.x FEMS Microbiol Lett 1998
Host vector system for high-level expression and purification of recombinant, enzymatically active alanine dehydrogenase of Mycobacterium tuberculosis. doi:10.1016/s0378-1119(98)00134-6 Gene 1998
[Effectiveness of complex treatment in combination with short-wave therapy and protease inhibitors in first detected patients with pulmonary tuberculosis]. Probl Tuberk 1997
The Mycobacterium tuberculosis 38-kDa antigen: overproduction in Escherichia coli, purification and characterization. doi:10.1016/0378-1119(92)90489-c Gene 1992
A fully modular vector system for the optimization of gene expression in Escherichia coli. doi:10.1016/0147-619x(91)90056-3 Plasmid 1991

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Conditional expression context (iModulons)

Member of 1 independently-modulated gene set(s): Central Carbon Metabolism.

iModulon membership (independently-modulated gene sets from a 647-sample RNA-seq compendium): the conditional co-expression context. Co-expression is a regulatory context, NOT a molecular function. Source: iModulonDB / modulome_mtb (Yoo 2022).

CRISPRi vulnerability

Vulnerability index -8.68 (95% CI -9.57 to -7.66). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Legacy record & comparison (Mycobrowser)

Mycobrowser functionThis is one of the three chains of the nonenzymatic component (cf(0) subunit) of the ATPase complex.

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb1337 · 100.0% identity
M. leprae ML1140 · 92.6% identity
M. marinum MMAR_4092 · 98.8% identity
M. smegmatis MSMEG_4941 · 96.6% identity
M. orygis RJtmp_001375 · 100.0% identity
M. abscessus MAB_1448 · 97.4% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WPS1 SwissProt · reviewed · Evidence at protein level
UniProt nameATP synthase subunit c
Curated functionF(1)F(0) ATP synthase produces ATP from ADP in the presence of a proton or sodium gradient. F-type ATPases consist of two structural domains, F(1) containing the extramembraneous catalytic core and F(0) containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation..; FUNCTION: Key component of the F(0) channel; it plays a direct role in translocation across the membrane. A homomeric c-ring of between 10-14 s.

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category C Energy production and conversion
Preferred nameatpE
eggNOG descriptionF(1)F(0) ATP synthase produces ATP from ADP in the presence of a proton or sodium gradient. F-type ATPases consist of two structural domains, F(1) containing the extramembraneous catalytic core and F(0) containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation
Orthologous groupCOG0636
KEGG orthology K02110
KEGG pathways map00190, map00195, map01100
KEGG modules M00157
Gene Ontology (123) GO:0003674, GO:0003824, GO:0005215, GO:0005575, GO:0005622, GO:0005623, GO:0006139, GO:0006163, GO:0006164, GO:0006725, GO:0006753, GO:0006754 +111 more

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.0 · quasi-invariant (3 sites), pN/pS underpowered
Polymorphic sites (≥ 0.1% of strains) 3 synonymous, 0 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Corynebacteriales

Genus-wide presence (~53 non-MTBC Mycobacterium) present in 53/53 (100%) · mean identity 97.0% · 4/4 closest MTBAP relatives
conserved across the genus (present in 53/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 3/13 non-Mycobacterium reference genomes (down to Corynebacteriales) · mean identity 92.9%
detected across the order Corynebacteriales (Corynebacterium/Nocardia/Rhodococcus/…) but not in more distant Actinomycetia — a Corynebacteriales-level gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis) essential

The two screens disagree on this gene: Tn-seq says essential (ES), CRISPRi says non-essential.

Two genome-wide screens disagree on this gene, and both are kept as they stand. They do not measure the same thing: the Tn-seq call (DeJesus 2017) reports tolerance to transposon insertion across the ORF, the CRISPRi call (Bosch 2021) reports tolerance to partial knockdown. A gene can absorb an insertion and still be required at full dosage, or the reverse. Here the CRISPRi estimate is a confident one (its `certain` flag is set, vulnerability index -8.676), so the disagreement is a genuine methodological tension rather than a weak fit. Atlas-wide, 12 gene(s) fall in this exact stratum, out of 24 showing this direction of disagreement.

DeJesus 2017 callES · essential
What the call meansessential: insertions absent across the whole ORF
TA sites (Himar1) 8 in the ORF — 7 in the essential state, 0 growth-defect, 1 non-essential, 0 growth-advantage. Saturation 0.125, mean read count 1. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 8 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.
CaveatRead with some caution: only 8 TA (Himar1) sites in the whole ORF (atlas median 13). The DeJesus 2017 call rests on fewer independent observations than for a longer gene. If this gene overlaps a neighbour (see Genomic-neighbour overlap section below), some of these 8 sites may fall inside the neighbour's ORF rather than its own, leaving even fewer truly informative sites than the raw count suggests. (P20.3)

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Drug resistance (WHO catalogue) bedaquiline

bedaquiline7 catalogued resistance-associated variant(s)

This gene carries mutations classed Associated with resistance (WHO grade 1–2) in the consolidated catalogue (WHO 2nd ed. 2023 + tb-profiler). Only the R-associated tier is shown; "uncertain" and empirical-only signals are excluded. Test a specific strain or variant with the resistance tester. Research context, not a clinical diagnostic.

Proteomics (mass spectrometry) detected

MS detectiondetected in 7 of 16 independent MS datasets
Integrated abundance201.0 ppm · rank 846/3519 (76.0th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox)

Predictionpredicted membrane protein (2 TM helixes)
DeepTMHMM classTM
TM helices (DeepTMHMM)2

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length81 aa
Molecular weight8.1 kDa
Theoretical pI4.78
GRAVY1.016 (hydrophobic)
Aliphatic index112.2
Aromaticity0.099
Instability index22.5 (stable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
ATP-synt_CPF00137.27 9.9e-1211–73 ATP synthase subunit C

3D structure (interactive — Mol*/pdbe-molstar)

Experimental structure 8j0s (PDBe), the strongest available structural evidence for this gene. Drag to rotate, scroll to zoom; hetero-groups (ligands, ions, waters hidden by default) shown as sticks.

Experimental structures (Protein Data Bank) 6 solved

PDBMethodResolutionCoverage
8j0s Electron Microscopy 2.58 Å 100%
8j0t Electron Microscopy 2.8 Å 100%
8jr0 Electron Microscopy 2.8 Å 100%
8j57 Electron Microscopy 2.85 Å 100%
8j58 Electron Microscopy 3.15 Å 100%
8jr1 Electron Microscopy 3.17 Å 100%

Experimentally solved structures mapped from the UniProt accession via PDBe/SIFTS (6 total; up to 8 shown, ranked by sequence coverage then resolution). An experimental structure is direct proof of the folded product and the strongest structural evidence — superseding the predicted ESMFold/AlphaFold models below for any covered region.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 95.3

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
8j0s-assembly1_9 1.00 0.95 0.95 0.95 100% 100% / 100% 5.0e-10 sig 8j0s-assembly1_9 Cryo-EM structure of Mycobacterium tuberculosis ATP synthase in complex with bedaquiline(BDQ)
8j0s-assembly1_5 1.00 0.95 0.95 0.95 100% 100% / 100% 6.3e-10 sig 8j0s-assembly1_5 Cryo-EM structure of Mycobacterium tuberculosis ATP synthase in complex with bedaquiline(BDQ)
8j0s-assembly1_6 1.00 0.95 0.95 0.95 100% 100% / 100% 7.5e-10 sig 8j0s-assembly1_6 Cryo-EM structure of Mycobacterium tuberculosis ATP synthase in complex with bedaquiline(BDQ)
8j0s-assembly1_2 1.00 0.95 0.95 0.95 100% 100% / 100% 7.9e-10 sig 8j0s-assembly1_2 Cryo-EM structure of Mycobacterium tuberculosis ATP synthase in complex with bedaquiline(BDQ)
8jr0-assembly1_2 1.00 0.94 0.94 0.94 100% 100% / 100% 5.9e-10 sig 8jr0-assembly1_2 Cryo-EM structure of Mycobacterium tuberculosis ATP synthase in complex with TBAJ-587

Foldseek search of the AlphaFold DB model (mean pLDDT 95.3, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon) operon of 10

Upstream (5' on genome)atpB (+ strand, 48 bp gap)
Downstream (3' on genome)atpF (+ strand, 30 bp gap)
Predicted operon Rv1303 · atpB · atpE · atpF · atpH · atpA · atpG · atpD · atpC · Rv1312

Neighbours from the H37Rv annotation (+ strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) operon of 10: Rv1303 · atpB · atpE · atpF · atpH · atpA · atpG · atpD · atpC · Rv1312 — agrees with the distance heuristic above
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT1345) exponential phase: operon of 11, Rv1303 · Rv1304 · Rv1305 · Rv1306 · Rv1307 · Rv1308 · Rv1309 · Rv1310 · Rv1311 · Rv1312 (coverage 168.26)
stationary phase: operon of 10, Rv1303 · Rv1304 · Rv1305 · Rv1306 · Rv1307 · Rv1308 · Rv1309 · Rv1310 · Rv1311 (coverage 28.96) — agrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Transcriptional regulation (signed TRN: ChIP-seq + TFOE)

Regulated by (3 TF) Rv2324 (activates) · Rv3249c (activates) · Rv3830c (represses)

Regulatory edges from the ISB signed transcriptional regulatory network (TF ChIP-seq binding, Minch 2015 + TF-overexpression response, Rustad 2014). An edge is regulatory evidence (binding and/or expression change), not necessarily direct. For a "hypothetical", membership in a known regulon (e.g. DosR dormancy, PhoP virulence) is a physiological-context lead, not a function.

Condition: Condition-blind by construction. These edges come from transcription-factor OVEREXPRESSION in a single laboratory condition, so a listed regulator is not a claim that it governs this gene in every circumstance. Measured counter-examples exist within this atlas (see Rv2516c, where the DosR regulon collapses under moxifloxacin while the gene itself rises). Read a regulator as 'capable of shifting this gene', and look for the condition before building a hypothesis on it.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: atpB (ATP synthase subunit A), high confidence (score 1000, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence). The pair is recorded in a curated database (pathway or complex membership) for M. tuberculosis genes themselves (score ≥ 200): a curated association, not a measurement in this organism. Its experimental-channel score is inherited from other proteomes.

Showing the 15 strongest of this gene's 233 partners at medium confidence (71 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 233 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv1304 atpB exp (transferred) curated ATP synthase subunit A 999 1000 ctx neighborhood:813 cooccurence:582 coexpression:957 experimental:997 database:984 textmining:754
Rv1307 atpH exp (transferred) curated ATP synthase subunit b/delta 999 1000 ctx neighborhood:836 coexpression:999 experimental:999 database:976 textmining:749
Rv1311 atpC exp (transferred) curated ATP synthase subunit epsilon 999 1000 ctx neighborhood:738 cooccurence:436 coexpression:958 experimental:997 database:970 textmining:569
Rv1306 atpF exp (transferred) curated ATP synthase subunit B 999 1000 ctx neighborhood:836 coexpression:960 experimental:997 database:900 textmining:648
Rv1310 atpD exp (transferred) curated ATP synthase subunit beta 999 1000 ctx neighborhood:613 coexpression:968 experimental:928 database:975 textmining:567
Rv1308 atpA exp (transferred) curated ATP synthase subunit alpha 999 1000 ctx neighborhood:783 coexpression:923 experimental:928 database:982 textmining:870
Rv1309 atpG exp (transferred) curated ATP synthase subunit gamma 999 1000 ctx neighborhood:783 coexpression:958 experimental:997 database:963 textmining:626
Rv1507c exp (transferred) curated hypothetical protein 985 983 coexpression:730 experimental:829 database:643
Rv1303 hypothetical protein 965 958 ctx neighborhood:813 cooccurence:667
Rv3628 ppa curated inorganic pyrophosphatase 953 940 coexpression:417 database:900
Rv3921c yidC exp (transferred) membrane protein insertase YidC 898 868 experimental:828
Rv2196 qcrB ubiquinol-cytochrome C reductase cytochrome subunit B 954 862 coexpression:862 textmining:683
Rv1300 hemK exp (transferred) release factor glutamine methyltransferase 856 857 ctx neighborhood:651 experimental:474
Rv2195 qcrA ubiquinol-cytochrome C reductase rieske iron-sulfur subunit 880 822 coexpression:822
Rv0719 rplF 50S ribosomal protein L6 832 821 coexpression:794

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: ATP synthase subunit C
  • MTBC0 PGAP product: F0F1 ATP synthase subunit C
  • Pfam (hmmscan --cut_ga): ATP-synt_C PF00137.27 (E=1e-11)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_215821.1)
  • Domains: Pfam-A via hmmscan --cut_ga — ATP-synt_C (PF00137.27)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG0636
  • Curated reference: UniProt P9WPS1 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 95.3)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 233 functional partner(s); context anchor atpB
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Experimental structures: PDBe/SIFTS UniProt→PDB mapping (Dana et al. 2019, doi:10.1093/nar/gky1114)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Transcriptional regulation: ISB signed TRN — TF ChIP-seq (Minch et al. 2015, doi:10.1038/ncomms6829) + TF overexpression (Rustad et al. 2014, doi:10.1186/gb-2014-15-11-502)
  • Drug resistance: consolidated catalogue, WHO 2nd ed. 2023 (9789240082410) + tb-profiler; only the resistance-associated tier (grade 1–2) is surfaced
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_001397|Rv1305|atpE
MDPTIAAGALIGGGLIMAGGAIGAGIGDGVAGNALISGVARQPEAQGRLFTPFFITVGLVEAAYFINLAFMALFVFATPVK